Bellicum Pharmaceuticals, Inc Earning Date (BLCM)

USA |NASDAQ |USD

BLCM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 28, 2022 Dec 2021 $0.00 - $0.98
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 28, 2022 Dec 2021 $250.00K - $0.00

Bellicum Pharmaceuticals, Inc's next earnings date is Monday, Mar 28, 2022 for the fiscal quarter ending Dec 2021.

BLCM Earnings Date & History Chart

BLCM Earnings & Revenue Forecast

BLCM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 0 $0.00 $0.00 $0.00

BLCM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-2.93 $-2.93 $-2.93

BLCM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.00 $0.00 $0.00

BLCM Earnings Date & Revenue History

BLCM Earnings History

|
Show More
Show More

BLCM Revenue History

|
Show More
Show More

Bellicum Pharmaceuticals, Inc Next Earnings Date & Report

BLCM Next Earnings Date & Report Preview: Dec 2021 (FQ)

BLCM's next earnings date is Monday, Mar 28, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Bellicum Pharmaceuticals, Inc's next quarterly earnings is $0.00, with a low EPS estimation of $0.00, and a high estimation of $0.00.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.92, the last 2 month trend is $-0.92, and the 3 month trend is $-0.92.

Based on analysts, the average revenue estimation is $250.00K, with a low revenue estimation of $250.00K, and a high estimation of $250.00K.

Bellicum Pharmaceuticals, Inc Previous Earnings Dates & Reports

BLCM Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Bellicum Pharmaceuticals, Inc's previous earnings date was Nov 3, 2021 for its fiscal quarter ended Sep 30, 2021.

BLCM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Bellicum Pharmaceuticals, Inc's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

BLCM's earnings per share (EPS) was $-6.66, beating the consensus analysts forecast of $-8.70 by -23.45% , and higher than the previous year's EPS (Dec 2019) by -72.16%.

Revenues were $500.00.

The company reported a net income of $-7.72K.

Bellicum Pharmaceuticals, Inc reported a free cash flow of $-55.38M for its fiscal year, compared to $-78.09M a year ago.

The company ended the fiscal year with $825.00K in total debt, a decrease of -97.78% compared to the previous year.